Home > Journals > International Angiology > Past Issues > International Angiology 2013 June;32(3) > International Angiology 2013 June;32(3):261-5

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

International Angiology 2013 June;32(3):261-5

Copyright © 2013 EDIZIONI MINERVA MEDICA

language: English

Venous symptoms in C0 and C1 patients: UIP consensus document

Benigni J. P. 1, Bihari I. 2, Rabe E. 3, Uhl J. F. 4, Partsch H. 5, Cornu-Thenard A. 6, Jawien A. 7

1 HIA Bégin, Saint Mandé, France; 2 Semmelweis Egyetem, Egészségügyi Fôiskolai Kar, Klinikai Tanszék, Budapest, Hungary; 3 Department of Dermatology, University of Bonn, Bonn, Germany; 4 Vascular Surgeon, URDIA Research Unit EA4465, Université Paris Descartes, Paris, France; 5 Dermatology, University of Wien, Wien, Austria; 6 Hôpital Saint-Antoine, Paris, France; 7 Department of Surgery, Ludwik Rydygier University Medical School, Bydgoszcz, Poland


PDF


This UIP document provides an update on venous symptoms in CO and C1 patients. The correlation between venous symptoms and the presence of telangiectases and/or reticular veins is one of the most controversial topics in chronic venous disorders. As symptoms may be non-specific of chronic venous disease, it is important to differentiate venous symptoms from symptoms of other causes. Some data from the Bonn Vein Study suggest that the risk to develop venous symptoms is increased in women, advanced age and obesity. Treatment is based on physical advice, elastic compression, venoactive drugs, sclerotherapy, correction of foot static disorders and reduction of body weight. Future research should be promoted on venous symptoms in epidemiological and follow-up studies, about the relationship between female hormone levels and symptomatic telangiectasias, and between venous pain and foot static disorders in C0s C1s patients.

top of page